English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51383198    線上人數 :  1009
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 		 
搜尋範圍 進階搜尋
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR
About TAIR

Browse By
Institution
Author
Title
Date
Statistics Chart
Institution Facts
Trend

News
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

Copyright
Publisher & Journal Policy
TAIR Copyright Conference Minutes

Related Links
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
Taiwan Academic Institutional Repository >  Browse by Author

"de petris l"

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-8 / 8 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-05-26T09:26:49Z Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: A phase II global study Spira A; Bordogna W; Balas B; Morcos P.N; Monnet A; Zeaiter A; Kim D.-W.; Kim D.-W.;Zeaiter A;Monnet A;Morcos P.N;Balas B;Bordogna W;Spira A;Mekhail T;Ramirez S.V;Bearz A;Moro-Sibilot D;Lena H;Hughes B;Chih-Hsin Yang;Govindan R;De Petris L;Ahn J.S;Ou S.-H.I; Ou S.-H.I; Ahn J.S; De Petris L; Govindan R; CHIH-HSIN YANG; Hughes B; Lena H; Moro-Sibilot D; Bearz A; Ramirez S.V; Mekhail T
臺大學術典藏 2020-05-26T09:26:49Z Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: A phase II global study Spira A; Bordogna W; Balas B; Morcos P.N; Monnet A; Zeaiter A; Kim D.-W.; Kim D.-W.;Zeaiter A;Monnet A;Morcos P.N;Balas B;Bordogna W;Spira A;Mekhail T;Ramirez S.V;Bearz A;Moro-Sibilot D;Lena H;Hughes B;Chih-Hsin Yang;Govindan R;De Petris L;Ahn J.S;Ou S.-H.I; Ou S.-H.I; Ahn J.S; De Petris L; Govindan R; CHIH-HSIN YANG; Hughes B; Lena H; Moro-Sibilot D; Bearz A; Ramirez S.V; Mekhail T
臺大學術典藏 2020-05-26T09:26:43Z Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer Ou S.-H.I.;Zeaiter A;Golding S;Bordogna W;Han J.-Y;Chih-Hsin Yang;Tessmer A;Dansin E;De Pas T;Crino L;Duruisseaux M;Moro-Sibilot D.L;Chiappori A;Kim D.-W;De Petris L;Camidge D.R;Socinski M.A;Gandhi L;Govindan R;Shaw A.T;Gadgeel S.M; Gadgeel S.M; Shaw A.T; Govindan R; Gandhi L; Socinski M.A; Camidge D.R; De Petris L; Kim D.-W; Chiappori A; Moro-Sibilot D.L; Duruisseaux M; Crino L; De Pas T; Dansin E; Tessmer A; CHIH-HSIN YANG; Han J.-Y; Bordogna W; Golding S; Zeaiter A; Ou S.-H.I.
臺大學術典藏 2020-05-26T09:26:43Z Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer Ou S.-H.I.;Zeaiter A;Golding S;Bordogna W;Han J.-Y;Chih-Hsin Yang;Tessmer A;Dansin E;De Pas T;Crino L;Duruisseaux M;Moro-Sibilot D.L;Chiappori A;Kim D.-W;De Petris L;Camidge D.R;Socinski M.A;Gandhi L;Govindan R;Shaw A.T;Gadgeel S.M; Gadgeel S.M; Shaw A.T; Govindan R; Gandhi L; Socinski M.A; Camidge D.R; De Petris L; Kim D.-W; Chiappori A; Moro-Sibilot D.L; Duruisseaux M; Crino L; De Pas T; Dansin E; Tessmer A; CHIH-HSIN YANG; Han J.-Y; Bordogna W; Golding S; Zeaiter A; Ou S.-H.I.
臺大學術典藏 2020-05-26T09:26:36Z Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer Shaw A.T.;Zeaiter A;Morcos P.N;Balas B;Bordogna W;Golding S;Dansin E;Ahn J.S;Popat S;Lena H;Crino L;Dingemans A.-M.C;Govindan R;Barlesi F;Kim D.-W;Gandhi L;Gadgeel S;De Petris L;Ou S.-H.I;Chih-Hsin Yang; CHIH-HSIN YANG; Ou S.-H.I; De Petris L; Gadgeel S; Gandhi L; Kim D.-W; Barlesi F; Govindan R; Dingemans A.-M.C; Crino L; Lena H; Popat S; Ahn J.S; Dansin E; Golding S; Bordogna W; Balas B; Morcos P.N; Zeaiter A; Shaw A.T.
臺大學術典藏 2020-05-26T09:26:36Z Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer Shaw A.T.;Zeaiter A;Morcos P.N;Balas B;Bordogna W;Golding S;Dansin E;Ahn J.S;Popat S;Lena H;Crino L;Dingemans A.-M.C;Govindan R;Barlesi F;Kim D.-W;Gandhi L;Gadgeel S;De Petris L;Ou S.-H.I;Chih-Hsin Yang; CHIH-HSIN YANG; Ou S.-H.I; De Petris L; Gadgeel S; Gandhi L; Kim D.-W; Barlesi F; Govindan R; Dingemans A.-M.C; Crino L; Lena H; Popat S; Ahn J.S; Dansin E; Golding S; Bordogna W; Balas B; Morcos P.N; Zeaiter A; Shaw A.T.
臺大學術典藏 2020-05-26T09:26:17Z Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer Ou S.-H.I;Gadgeel S.M;Barlesi F;Chih-Hsin Yang;De Petris L;Kim D.-W;Govindan R;Dingemans A.-M;Crino L;L?na H;Popat S;Ahn J.S;Dansin E;Mitry E;M?ller B;Bordogna W;Balas B;Morcos P.N;Shaw A.T.; Ou S.-H.I; Gadgeel S.M; Barlesi F; CHIH-HSIN YANG; De Petris L; Kim D.-W; Govindan R; Dingemans A.-M; Crino L; Léna H; Popat S; Ahn J.S; Dansin E; Mitry E; Müller B; Bordogna W; Balas B; Morcos P.N; Shaw A.T.
臺大學術典藏 2020-05-26T09:26:17Z Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer Ou S.-H.I;Gadgeel S.M;Barlesi F;Chih-Hsin Yang;De Petris L;Kim D.-W;Govindan R;Dingemans A.-M;Crino L;L?na H;Popat S;Ahn J.S;Dansin E;Mitry E;M?ller B;Bordogna W;Balas B;Morcos P.N;Shaw A.T.; Ou S.-H.I; Gadgeel S.M; Barlesi F; CHIH-HSIN YANG; De Petris L; Kim D.-W; Govindan R; Dingemans A.-M; Crino L; Léna H; Popat S; Ahn J.S; Dansin E; Mitry E; Müller B; Bordogna W; Balas B; Morcos P.N; Shaw A.T.

Showing items 1-8 of 8  (1 Page(s) Totally)
1 
View [10|25|50] records per page

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team